Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-10-23
|
pubmed:abstractText |
Patients presenting genital intraepithelial neoplasia and/or flat condyloma were treated with DTrp6-LH-RH (triptorelin) to induce a transitory suppression of estrogens. This treatment led in some cases to a complete clinical and histological regression accompanied by a disappearance of human papillomavirus sequences as detected by molecular hybridization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0753-3322
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2550098-Antineoplastic Agents,
pubmed-meshheading:2550098-Female,
pubmed-meshheading:2550098-Gonadotropin-Releasing Hormone,
pubmed-meshheading:2550098-Humans,
pubmed-meshheading:2550098-Papillomaviridae,
pubmed-meshheading:2550098-Triptorelin Pamoate,
pubmed-meshheading:2550098-Tumor Virus Infections,
pubmed-meshheading:2550098-Uterine Cervical Neoplasms
|
pubmed:year |
1989
|
pubmed:articleTitle |
Regression of the malignant aspects of intraepithelial neoplasias following an LH-RH agonist treatment and detection of human papillomavirus by molecular hybridization.
|
pubmed:affiliation |
Institut du Cancer et d'Immunogénétique, Hôpital Paul-Brousse, Villejuif, France.
|
pubmed:publicationType |
Journal Article
|